Home / Treatments / Drug Ad Oth Oral
Drug Ad Oth Oral denials: what the review data shows
Independent reviewers have decided 42 published cases where an insurer denied drug ad oth oral — and they overturned the insurer 90.5% of the time. If your denial is in this category, the odds say: appeal.
Published decisions
42
2001–2026
Overturned
90.5%
38 denials reversed
By denial reason
The excuse on the letter changes the odds — and the counter-strategy.
| Denial reason | Decisions | Overturned |
|---|---|---|
| medical necessity | 38 | 94.7% |
Within this category
Subcategories with at least 15 published decisions.
| Subcategory | Decisions | Overturned |
|---|---|---|
| Injection Admin Drugs | 29 | 86.2% |
How to use this in your appeal
These are outcomes from California’s external review program — an independent physician panel that binds the insurer. Every state has an equivalent process, and internal appeals succeed even more often. Cite the category outcome when you appeal: reviewers routinely find that denials like yours didn’t hold up.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY
Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.